DIVIS: Integrated and Customizable Pipeline for Cancer Genome Sequencing Analysis and Interpretation
Next-generation sequencing (NGS) has drastically enhanced human cancer research, but diverse sequencing strategies, complicated open-source software, and the identification of massive numbers of mutations have limited the clinical application of NGS. Here, we first presented GPyFlow, a lightweight t...
Saved in:
Published in: | Frontiers in oncology Vol. 11; p. 672597 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Frontiers Media S.A
08-06-2021
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Next-generation sequencing (NGS) has drastically enhanced human cancer research, but diverse sequencing strategies, complicated open-source software, and the identification of massive numbers of mutations have limited the clinical application of NGS. Here, we first presented GPyFlow, a lightweight tool that flexibly customizes, executes, and shares workflows. We then introduced DIVIS, a customizable pipeline based on GPyFlow that integrates read preprocessing, alignment, variant detection, and annotation of whole-genome sequencing, whole-exome sequencing, and gene-panel sequencing. By default, DIVIS screens variants from multiple callers and generates a standard variant-detection format list containing caller evidence for each sample, which is compatible with advanced analyses. Lastly, DIVIS generates a statistical report, including command lines, parameters, quality-control indicators, and mutation summary. DIVIS substantially facilitates complex cancer genome sequencing analyses by means of a single powerful and easy-to-use command. The DIVIS code is freely available at
https://github.com/niu-lab/DIVIS
, and the docker image can be downloaded from
https://hub.docker.com/repository/docker/sunshinerain/divis
. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Yongsheng Kevin Li, Hainan Medical University, China This article was submitted to Cancer Genetics, a section of the journal Frontiers in Oncology Reviewed by: Haishan Huang, Wenzhou Medical University, China; Shuang Li, Huazhong University of Science and Technology, China |
ISSN: | 2234-943X 2234-943X |
DOI: | 10.3389/fonc.2021.672597 |